| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome, Human | 37 | 2023 | 824 | 6.180 |
Why?
|
| Neoplasms | 38 | 2024 | 3248 | 4.260 |
Why?
|
| Mutation | 42 | 2024 | 4374 | 3.520 |
Why?
|
| Genomics | 19 | 2023 | 855 | 3.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 18 | 2024 | 1346 | 1.980 |
Why?
|
| Oncogenes | 8 | 2024 | 100 | 1.860 |
Why?
|
| Gene Fusion | 5 | 2023 | 40 | 1.560 |
Why?
|
| DNA Copy Number Variations | 14 | 2020 | 191 | 1.460 |
Why?
|
| Computational Biology | 7 | 2020 | 584 | 1.410 |
Why?
|
| Sequence Analysis, DNA | 12 | 2022 | 908 | 1.340 |
Why?
|
| Gene Rearrangement | 6 | 2020 | 179 | 1.280 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2022 | 539 | 1.250 |
Why?
|
| Whole Genome Sequencing | 12 | 2024 | 108 | 1.240 |
Why?
|
| Chromothripsis | 4 | 2022 | 9 | 1.230 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2024 | 44 | 1.100 |
Why?
|
| Evolution, Molecular | 9 | 2020 | 891 | 0.910 |
Why?
|
| Genomic Structural Variation | 4 | 2020 | 9 | 0.880 |
Why?
|
| DNA Replication | 1 | 2024 | 177 | 0.830 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2024 | 305 | 0.830 |
Why?
|
| Adenocarcinoma | 6 | 2020 | 1215 | 0.820 |
Why?
|
| Algorithms | 5 | 2024 | 2014 | 0.810 |
Why?
|
| Exome | 7 | 2020 | 141 | 0.790 |
Why?
|
| DNA Mutational Analysis | 5 | 2020 | 547 | 0.720 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2017 | 1105 | 0.710 |
Why?
|
| Humans | 66 | 2024 | 96093 | 0.700 |
Why?
|
| Brain Neoplasms | 3 | 2023 | 855 | 0.680 |
Why?
|
| DNA Transposable Elements | 6 | 2011 | 179 | 0.660 |
Why?
|
| Transcription, Genetic | 1 | 2024 | 1191 | 0.630 |
Why?
|
| RNA, Long Noncoding | 4 | 2024 | 130 | 0.610 |
Why?
|
| Genome, Plant | 6 | 2011 | 103 | 0.600 |
Why?
|
| Transcriptome | 7 | 2023 | 769 | 0.560 |
Why?
|
| Retroelements | 5 | 2020 | 50 | 0.550 |
Why?
|
| Virus Integration | 4 | 2020 | 17 | 0.520 |
Why?
|
| Exons | 2 | 2020 | 454 | 0.510 |
Why?
|
| Chromatin | 4 | 2022 | 446 | 0.510 |
Why?
|
| Phosphatidylinositol 3-Kinases | 6 | 2017 | 284 | 0.500 |
Why?
|
| Telomere | 3 | 2020 | 121 | 0.470 |
Why?
|
| Zea mays | 3 | 2009 | 28 | 0.470 |
Why?
|
| Signal Transduction | 13 | 2020 | 3581 | 0.470 |
Why?
|
| Databases, Genetic | 7 | 2020 | 282 | 0.460 |
Why?
|
| Long Interspersed Nucleotide Elements | 3 | 2020 | 14 | 0.460 |
Why?
|
| Genomic Instability | 3 | 2024 | 88 | 0.450 |
Why?
|
| Disease Progression | 1 | 2019 | 1564 | 0.450 |
Why?
|
| Telomerase | 6 | 2020 | 68 | 0.440 |
Why?
|
| Melanoma | 2 | 2017 | 497 | 0.430 |
Why?
|
| RNA Splicing | 2 | 2020 | 159 | 0.430 |
Why?
|
| Metabolic Networks and Pathways | 4 | 2020 | 102 | 0.430 |
Why?
|
| Models, Genetic | 1 | 2019 | 983 | 0.420 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2020 | 465 | 0.410 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 2463 | 0.400 |
Why?
|
| Gene Expression Profiling | 8 | 2023 | 1533 | 0.400 |
Why?
|
| Stomach Neoplasms | 2 | 2017 | 310 | 0.390 |
Why?
|
| Colorectal Neoplasms | 2 | 2019 | 1069 | 0.390 |
Why?
|
| Prostatic Neoplasms | 4 | 2024 | 1798 | 0.380 |
Why?
|
| Molecular Targeted Therapy | 5 | 2017 | 305 | 0.370 |
Why?
|
| Gene Dosage | 4 | 2020 | 212 | 0.360 |
Why?
|
| Software | 2 | 2020 | 698 | 0.350 |
Why?
|
| Carcinoma | 1 | 2014 | 448 | 0.350 |
Why?
|
| Rectal Neoplasms | 1 | 2012 | 134 | 0.340 |
Why?
|
| Head and Neck Neoplasms | 2 | 2015 | 1089 | 0.340 |
Why?
|
| DNA Tumor Viruses | 1 | 2020 | 1 | 0.320 |
Why?
|
| Cloud Computing | 2 | 2020 | 14 | 0.320 |
Why?
|
| Thyroid Neoplasms | 1 | 2014 | 443 | 0.320 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 625 | 0.320 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2014 | 382 | 0.320 |
Why?
|
| Tumor Virus Infections | 1 | 2020 | 83 | 0.310 |
Why?
|
| DNA Methylation | 8 | 2020 | 703 | 0.310 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2024 | 303 | 0.310 |
Why?
|
| Tumor Hypoxia | 1 | 2020 | 43 | 0.310 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2024 | 528 | 0.300 |
Why?
|
| Carcinogenesis | 2 | 2020 | 235 | 0.300 |
Why?
|
| Oncogene Fusion | 2 | 2020 | 10 | 0.300 |
Why?
|
| Promoter Regions, Genetic | 5 | 2020 | 992 | 0.300 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2020 | 164 | 0.300 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 220 | 0.290 |
Why?
|
| Male | 16 | 2024 | 45870 | 0.290 |
Why?
|
| Plants | 1 | 2009 | 127 | 0.290 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2018 | 367 | 0.280 |
Why?
|
| Colonic Neoplasms | 1 | 2012 | 589 | 0.270 |
Why?
|
| Cell Cycle Proteins | 2 | 2024 | 412 | 0.270 |
Why?
|
| Glioblastoma | 4 | 2015 | 286 | 0.270 |
Why?
|
| Genetic Variation | 3 | 2020 | 1423 | 0.270 |
Why?
|
| Genome | 3 | 2022 | 407 | 0.260 |
Why?
|
| Mutation Rate | 3 | 2020 | 55 | 0.260 |
Why?
|
| Kidney Neoplasms | 3 | 2018 | 558 | 0.250 |
Why?
|
| DNA, Neoplasm | 3 | 2020 | 272 | 0.250 |
Why?
|
| DNA, Intergenic | 2 | 2020 | 28 | 0.250 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2017 | 134 | 0.240 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2017 | 217 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2017 | 367 | 0.240 |
Why?
|
| Nuclear Proteins | 4 | 2022 | 750 | 0.230 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2024 | 15 | 0.220 |
Why?
|
| Tandem Repeat Sequences | 1 | 2024 | 31 | 0.220 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2024 | 64 | 0.220 |
Why?
|
| Female | 15 | 2024 | 50030 | 0.220 |
Why?
|
| Animals | 9 | 2024 | 28914 | 0.220 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2024 | 85 | 0.210 |
Why?
|
| Mutagenesis, Insertional | 4 | 2020 | 116 | 0.210 |
Why?
|
| Esophageal Neoplasms | 1 | 2017 | 346 | 0.210 |
Why?
|
| Genes, p53 | 2 | 2015 | 109 | 0.210 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2017 | 319 | 0.200 |
Why?
|
| Cell Proliferation | 3 | 2020 | 1754 | 0.200 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 2777 | 0.200 |
Why?
|
| Base Sequence | 8 | 2020 | 2344 | 0.200 |
Why?
|
| Genes, Neoplasm | 3 | 2018 | 39 | 0.190 |
Why?
|
| Glioma | 2 | 2016 | 321 | 0.190 |
Why?
|
| Biomarkers, Tumor | 3 | 2020 | 1664 | 0.190 |
Why?
|
| Starfish | 1 | 2022 | 4 | 0.190 |
Why?
|
| Molecular Sequence Data | 9 | 2014 | 3040 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2020 | 2494 | 0.190 |
Why?
|
| DNA Repair | 4 | 2020 | 376 | 0.180 |
Why?
|
| Herpesvirus 4, Human | 2 | 2020 | 126 | 0.180 |
Why?
|
| Mutagenesis | 2 | 2020 | 202 | 0.180 |
Why?
|
| Tachykinins | 1 | 2021 | 13 | 0.170 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2021 | 18 | 0.170 |
Why?
|
| Genes, Plant | 5 | 2012 | 102 | 0.170 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2020 | 149 | 0.170 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 2883 | 0.170 |
Why?
|
| Genome, Mitochondrial | 1 | 2020 | 32 | 0.160 |
Why?
|
| Mice | 4 | 2024 | 12538 | 0.150 |
Why?
|
| Cellular Senescence | 1 | 2020 | 106 | 0.150 |
Why?
|
| Repressor Proteins | 1 | 2022 | 447 | 0.150 |
Why?
|
| Information Dissemination | 1 | 2020 | 126 | 0.150 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 1092 | 0.150 |
Why?
|
| Transcription Factors | 5 | 2018 | 1730 | 0.140 |
Why?
|
| Proteome | 3 | 2014 | 156 | 0.140 |
Why?
|
| Sex Characteristics | 1 | 2020 | 339 | 0.140 |
Why?
|
| RNA, Messenger | 3 | 2020 | 2090 | 0.140 |
Why?
|
| Uveal Neoplasms | 1 | 2017 | 11 | 0.140 |
Why?
|
| Mice, Nude | 2 | 2017 | 830 | 0.140 |
Why?
|
| Proteogenomics | 1 | 2017 | 7 | 0.130 |
Why?
|
| Germ-Line Mutation | 1 | 2020 | 381 | 0.130 |
Why?
|
| Cell Cycle | 2 | 2020 | 516 | 0.130 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2016 | 4 | 0.120 |
Why?
|
| DNA | 1 | 2022 | 1332 | 0.120 |
Why?
|
| MicroRNAs | 4 | 2016 | 592 | 0.120 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2016 | 18 | 0.120 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 112 | 0.120 |
Why?
|
| RNA | 1 | 2020 | 605 | 0.120 |
Why?
|
| Chromosomes, Plant | 3 | 2009 | 39 | 0.120 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 2020 | 137 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2020 | 157 | 0.110 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2015 | 72 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 227 | 0.110 |
Why?
|
| Receptors, Androgen | 1 | 2015 | 120 | 0.110 |
Why?
|
| RNA, Neoplasm | 1 | 2015 | 89 | 0.110 |
Why?
|
| Chromosome Aberrations | 2 | 2013 | 393 | 0.110 |
Why?
|
| ras Proteins | 1 | 2015 | 134 | 0.110 |
Why?
|
| X-linked Nuclear Protein | 2 | 2020 | 11 | 0.110 |
Why?
|
| Molecular Typing | 1 | 2014 | 19 | 0.110 |
Why?
|
| Epigenesis, Genetic | 2 | 2016 | 554 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 2 | 2020 | 259 | 0.100 |
Why?
|
| Gene Frequency | 2 | 2020 | 703 | 0.100 |
Why?
|
| Papillomaviridae | 1 | 2014 | 180 | 0.100 |
Why?
|
| Carcinoma, Papillary | 1 | 2014 | 161 | 0.100 |
Why?
|
| Cell Lineage | 1 | 2015 | 324 | 0.100 |
Why?
|
| Ovarian Neoplasms | 3 | 2020 | 800 | 0.100 |
Why?
|
| Thyroid Gland | 1 | 2014 | 281 | 0.100 |
Why?
|
| DNA, Plant | 2 | 2009 | 48 | 0.100 |
Why?
|
| Genes, p16 | 1 | 2012 | 10 | 0.100 |
Why?
|
| Eragrostis | 1 | 2012 | 1 | 0.100 |
Why?
|
| Protein Kinases | 1 | 2014 | 216 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 684 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 241 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2019 | 3107 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2014 | 526 | 0.090 |
Why?
|
| Bryopsida | 2 | 2011 | 2 | 0.090 |
Why?
|
| Child | 1 | 2023 | 7626 | 0.090 |
Why?
|
| Biological Evolution | 2 | 2011 | 1030 | 0.090 |
Why?
|
| Selaginellaceae | 1 | 2011 | 1 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2012 | 358 | 0.090 |
Why?
|
| Gene Regulatory Networks | 2 | 2020 | 321 | 0.090 |
Why?
|
| Computer Simulation | 2 | 2020 | 1158 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2016 | 2940 | 0.080 |
Why?
|
| Sex Factors | 1 | 2014 | 1133 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2014 | 483 | 0.080 |
Why?
|
| Base Composition | 1 | 2020 | 38 | 0.080 |
Why?
|
| Cerebral Cortex | 1 | 2015 | 615 | 0.080 |
Why?
|
| DNA-Binding Proteins | 3 | 2018 | 1267 | 0.080 |
Why?
|
| MEF2 Transcription Factors | 1 | 2020 | 10 | 0.080 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2020 | 10 | 0.080 |
Why?
|
| Endometrial Neoplasms | 1 | 2013 | 228 | 0.080 |
Why?
|
| Genome-Wide Association Study | 2 | 2020 | 1763 | 0.080 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 25 | 0.080 |
Why?
|
| Cluster Analysis | 3 | 2016 | 392 | 0.080 |
Why?
|
| Genes, myc | 1 | 2020 | 41 | 0.080 |
Why?
|
| Hepatitis B virus | 1 | 2020 | 48 | 0.080 |
Why?
|
| Base Pairing | 1 | 2009 | 56 | 0.080 |
Why?
|
| Databases, Nucleic Acid | 1 | 2009 | 42 | 0.080 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2020 | 141 | 0.080 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2020 | 82 | 0.080 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 127 | 0.080 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 98 | 0.080 |
Why?
|
| Cell Hypoxia | 1 | 2020 | 188 | 0.070 |
Why?
|
| Cenchrus | 1 | 2008 | 1 | 0.070 |
Why?
|
| Pennisetum | 1 | 2008 | 1 | 0.070 |
Why?
|
| Reproduction, Asexual | 1 | 2008 | 3 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 164 | 0.070 |
Why?
|
| Linear Models | 1 | 2009 | 438 | 0.070 |
Why?
|
| Multiple Myeloma | 1 | 2012 | 354 | 0.070 |
Why?
|
| Ubiquitin Thiolesterase | 2 | 2018 | 66 | 0.070 |
Why?
|
| APOBEC-1 Deaminase | 1 | 2017 | 2 | 0.070 |
Why?
|
| Caspase 8 | 1 | 2017 | 35 | 0.070 |
Why?
|
| Programmed Cell Death 1 Ligand 2 Protein | 1 | 2017 | 11 | 0.070 |
Why?
|
| Keratins | 1 | 2017 | 63 | 0.060 |
Why?
|
| HLA-A Antigens | 1 | 2017 | 40 | 0.060 |
Why?
|
| Receptor, ErbB-3 | 1 | 2017 | 19 | 0.060 |
Why?
|
| Prognosis | 2 | 2020 | 4029 | 0.060 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 52 | 0.060 |
Why?
|
| Human papillomavirus 16 | 1 | 2017 | 45 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 465 | 0.060 |
Why?
|
| DNA, Mitochondrial | 2 | 2020 | 197 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2017 | 98 | 0.060 |
Why?
|
| Papillomavirus Infections | 1 | 2020 | 301 | 0.060 |
Why?
|
| RNA, Plant | 3 | 2011 | 24 | 0.060 |
Why?
|
| Neurons | 1 | 2015 | 1653 | 0.060 |
Why?
|
| Open Reading Frames | 2 | 2020 | 124 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2018 | 301 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 555 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 180 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2020 | 1010 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1958 | 0.060 |
Why?
|
| Age Factors | 1 | 2020 | 1963 | 0.060 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2024 | 2 | 0.060 |
Why?
|
| Proteomics | 1 | 2017 | 268 | 0.050 |
Why?
|
| B7-H1 Antigen | 1 | 2017 | 305 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2018 | 1546 | 0.050 |
Why?
|
| Oryza | 3 | 2009 | 45 | 0.050 |
Why?
|
| Gene Duplication | 3 | 2009 | 129 | 0.050 |
Why?
|
| Apoptosis | 1 | 2020 | 1760 | 0.050 |
Why?
|
| Indoles | 1 | 2024 | 317 | 0.050 |
Why?
|
| United States | 1 | 2015 | 7767 | 0.050 |
Why?
|
| Chromosomal Instability | 1 | 2020 | 23 | 0.040 |
Why?
|
| DNA Breaks | 1 | 2020 | 4 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2020 | 33 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 3147 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 64 | 0.040 |
Why?
|
| Magnoliopsida | 2 | 2011 | 26 | 0.040 |
Why?
|
| Sorghum | 2 | 2009 | 4 | 0.040 |
Why?
|
| Synteny | 2 | 2009 | 30 | 0.040 |
Why?
|
| CpG Islands | 1 | 2019 | 169 | 0.040 |
Why?
|
| Phenotype | 2 | 2018 | 2579 | 0.040 |
Why?
|
| Plant Proteins | 2 | 2011 | 143 | 0.040 |
Why?
|
| beta Catenin | 1 | 2020 | 266 | 0.040 |
Why?
|
| Eukaryotic Initiation Factor-1 | 1 | 2017 | 1 | 0.030 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2017 | 6 | 0.030 |
Why?
|
| Monosomy | 1 | 2017 | 12 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 305 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2017 | 30 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 107 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2022 | 451 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 515 | 0.030 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2017 | 110 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 1268 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2017 | 282 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 563 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 206 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2017 | 263 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2020 | 10286 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2017 | 162 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 60 | 0.030 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2016 | 62 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2040 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2016 | 90 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2015 | 61 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 102 | 0.030 |
Why?
|
| Poly A | 1 | 2015 | 23 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2014 | 15 | 0.030 |
Why?
|
| Clone Cells | 1 | 2015 | 223 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 2015 | 151 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2014 | 67 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2020 | 725 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2014 | 229 | 0.030 |
Why?
|
| Phylogeny | 2 | 2011 | 1275 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 404 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 793 | 0.030 |
Why?
|
| DNA Polymerase II | 1 | 2013 | 10 | 0.030 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2013 | 14 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 884 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 901 | 0.020 |
Why?
|
| Mutagens | 1 | 2012 | 30 | 0.020 |
Why?
|
| Ethiopia | 1 | 2012 | 36 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 930 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 77 | 0.020 |
Why?
|
| Microsatellite Instability | 1 | 2012 | 64 | 0.020 |
Why?
|
| Adolescent | 2 | 2015 | 9896 | 0.020 |
Why?
|
| Survival Rate | 1 | 2016 | 1985 | 0.020 |
Why?
|
| Chlamydomonas | 1 | 2011 | 20 | 0.020 |
Why?
|
| Cell Movement | 1 | 2015 | 816 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 301 | 0.020 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2011 | 99 | 0.020 |
Why?
|
| RNA Editing | 1 | 2011 | 48 | 0.020 |
Why?
|
| Centromere | 1 | 2009 | 27 | 0.020 |
Why?
|
| Physical Chromosome Mapping | 1 | 2009 | 27 | 0.020 |
Why?
|
| Crops, Agricultural | 1 | 2009 | 18 | 0.020 |
Why?
|
| Ploidies | 1 | 2009 | 41 | 0.020 |
Why?
|
| Inbreeding | 1 | 2009 | 48 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2009 | 175 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2008 | 34 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2009 | 260 | 0.020 |
Why?
|
| Dehydration | 1 | 2007 | 20 | 0.020 |
Why?
|
| Chlamydomonas reinhardtii | 1 | 2007 | 19 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2009 | 444 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2008 | 648 | 0.020 |
Why?
|
| Multigene Family | 1 | 2007 | 213 | 0.020 |
Why?
|
| Arabidopsis Proteins | 1 | 2008 | 144 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2009 | 1083 | 0.020 |
Why?
|
| Middle Aged | 2 | 2016 | 28361 | 0.010 |
Why?
|
| Adult | 2 | 2016 | 28716 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 340 | 0.010 |
Why?
|
| Arabidopsis | 1 | 2007 | 331 | 0.010 |
Why?
|
| Brain | 1 | 2015 | 2482 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 20962 | 0.010 |
Why?
|